Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique

Bedaquiline was recommended by the World Health Organization as the preferred option in treatment of multidrug-resistant tuberculosis (MDR-TB) with long regimens. However, no recommendation was given for the short MDR-TB regimen. Data from our small cohort of patients who switched from injectable dr...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2019-10, Vol.69 (10), p.1809-1811
Main Authors: Bastard, Mathieu, Molfino, Lucas, Mutaquiha, Cláudia, Galindo, Miriam Arago, Zindoga, Pereira, Vaz, Deise, Mahinça, Ivan, DuCros, Philipp, Rusch, Barbara, Telnov, Alex
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c287t-923e5d7e115278fdf9a9811ce69875721091245064be3a140137b56b2b6352db3
cites cdi_FETCH-LOGICAL-c287t-923e5d7e115278fdf9a9811ce69875721091245064be3a140137b56b2b6352db3
container_end_page 1811
container_issue 10
container_start_page 1809
container_title Clinical infectious diseases
container_volume 69
creator Bastard, Mathieu
Molfino, Lucas
Mutaquiha, Cláudia
Galindo, Miriam Arago
Zindoga, Pereira
Vaz, Deise
Mahinça, Ivan
DuCros, Philipp
Rusch, Barbara
Telnov, Alex
description Bedaquiline was recommended by the World Health Organization as the preferred option in treatment of multidrug-resistant tuberculosis (MDR-TB) with long regimens. However, no recommendation was given for the short MDR-TB regimen. Data from our small cohort of patients who switched from injectable drug to bedaquiline suggest that a bedaquiline-based short regimen is effective and safe.
doi_str_mv 10.1093/cid/ciz196
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2196514447</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2196514447</sourcerecordid><originalsourceid>FETCH-LOGICAL-c287t-923e5d7e115278fdf9a9811ce69875721091245064be3a140137b56b2b6352db3</originalsourceid><addsrcrecordid>eNpFkUtLHUEQhRuJ-Iobf0DoZQhM7OqenscyMZoIisK9WQ_9qNGWmWntByH3B_k7bbkmLooqDh-n4BxCToB9BdaLU-NsmQ30zQ45ACnaqpE9fCg3k11Vd6LbJ4cxPjAG0DG5R_YF6xkwDgfkeR1QpRmXRG9yMn7GSP1Ib1VyRYt09cclc--WO3oR_EzVQi-XBzRJ6Qnpj5DvaPL0O1r1lN3klqLl8Eqv7n1IdJXUYlWwboOWvn8afaDXeUrOFoMqYHSxgImus8Zg8uSLQN1Cr_1Gzdo9ZfxIdkc1RTx-20fk98X5-uxXdXXz8_Ls21VleNemqucCpW0RQPK2G-3Yq74DMNj0XStbXuICXkvW1BqFgpqBaLVsNNeNkNxqcUQ-b30fgy9vYxpmFw1Ok1rQ5zjwErKEuq7bgn7Zoib4GAOOw2Nwswp_B2DDay9D6WXY9lLgT2--Wc9o_6P_ihAv8dmMhA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2196514447</pqid></control><display><type>article</type><title>Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique</title><source>Oxford Journals Online</source><creator>Bastard, Mathieu ; Molfino, Lucas ; Mutaquiha, Cláudia ; Galindo, Miriam Arago ; Zindoga, Pereira ; Vaz, Deise ; Mahinça, Ivan ; DuCros, Philipp ; Rusch, Barbara ; Telnov, Alex</creator><creatorcontrib>Bastard, Mathieu ; Molfino, Lucas ; Mutaquiha, Cláudia ; Galindo, Miriam Arago ; Zindoga, Pereira ; Vaz, Deise ; Mahinça, Ivan ; DuCros, Philipp ; Rusch, Barbara ; Telnov, Alex</creatorcontrib><description>Bedaquiline was recommended by the World Health Organization as the preferred option in treatment of multidrug-resistant tuberculosis (MDR-TB) with long regimens. However, no recommendation was given for the short MDR-TB regimen. Data from our small cohort of patients who switched from injectable drug to bedaquiline suggest that a bedaquiline-based short regimen is effective and safe.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/cid/ciz196</identifier><identifier>PMID: 30901021</identifier><language>eng</language><publisher>United States</publisher><ispartof>Clinical infectious diseases, 2019-10, Vol.69 (10), p.1809-1811</ispartof><rights>The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c287t-923e5d7e115278fdf9a9811ce69875721091245064be3a140137b56b2b6352db3</citedby><cites>FETCH-LOGICAL-c287t-923e5d7e115278fdf9a9811ce69875721091245064be3a140137b56b2b6352db3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30901021$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bastard, Mathieu</creatorcontrib><creatorcontrib>Molfino, Lucas</creatorcontrib><creatorcontrib>Mutaquiha, Cláudia</creatorcontrib><creatorcontrib>Galindo, Miriam Arago</creatorcontrib><creatorcontrib>Zindoga, Pereira</creatorcontrib><creatorcontrib>Vaz, Deise</creatorcontrib><creatorcontrib>Mahinça, Ivan</creatorcontrib><creatorcontrib>DuCros, Philipp</creatorcontrib><creatorcontrib>Rusch, Barbara</creatorcontrib><creatorcontrib>Telnov, Alex</creatorcontrib><title>Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique</title><title>Clinical infectious diseases</title><addtitle>Clin Infect Dis</addtitle><description>Bedaquiline was recommended by the World Health Organization as the preferred option in treatment of multidrug-resistant tuberculosis (MDR-TB) with long regimens. However, no recommendation was given for the short MDR-TB regimen. Data from our small cohort of patients who switched from injectable drug to bedaquiline suggest that a bedaquiline-based short regimen is effective and safe.</description><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpFkUtLHUEQhRuJ-Iobf0DoZQhM7OqenscyMZoIisK9WQ_9qNGWmWntByH3B_k7bbkmLooqDh-n4BxCToB9BdaLU-NsmQ30zQ45ACnaqpE9fCg3k11Vd6LbJ4cxPjAG0DG5R_YF6xkwDgfkeR1QpRmXRG9yMn7GSP1Ib1VyRYt09cclc--WO3oR_EzVQi-XBzRJ6Qnpj5DvaPL0O1r1lN3klqLl8Eqv7n1IdJXUYlWwboOWvn8afaDXeUrOFoMqYHSxgImus8Zg8uSLQN1Cr_1Gzdo9ZfxIdkc1RTx-20fk98X5-uxXdXXz8_Ls21VleNemqucCpW0RQPK2G-3Yq74DMNj0XStbXuICXkvW1BqFgpqBaLVsNNeNkNxqcUQ-b30fgy9vYxpmFw1Ok1rQ5zjwErKEuq7bgn7Zoib4GAOOw2Nwswp_B2DDay9D6WXY9lLgT2--Wc9o_6P_ihAv8dmMhA</recordid><startdate>20191030</startdate><enddate>20191030</enddate><creator>Bastard, Mathieu</creator><creator>Molfino, Lucas</creator><creator>Mutaquiha, Cláudia</creator><creator>Galindo, Miriam Arago</creator><creator>Zindoga, Pereira</creator><creator>Vaz, Deise</creator><creator>Mahinça, Ivan</creator><creator>DuCros, Philipp</creator><creator>Rusch, Barbara</creator><creator>Telnov, Alex</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20191030</creationdate><title>Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique</title><author>Bastard, Mathieu ; Molfino, Lucas ; Mutaquiha, Cláudia ; Galindo, Miriam Arago ; Zindoga, Pereira ; Vaz, Deise ; Mahinça, Ivan ; DuCros, Philipp ; Rusch, Barbara ; Telnov, Alex</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c287t-923e5d7e115278fdf9a9811ce69875721091245064be3a140137b56b2b6352db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bastard, Mathieu</creatorcontrib><creatorcontrib>Molfino, Lucas</creatorcontrib><creatorcontrib>Mutaquiha, Cláudia</creatorcontrib><creatorcontrib>Galindo, Miriam Arago</creatorcontrib><creatorcontrib>Zindoga, Pereira</creatorcontrib><creatorcontrib>Vaz, Deise</creatorcontrib><creatorcontrib>Mahinça, Ivan</creatorcontrib><creatorcontrib>DuCros, Philipp</creatorcontrib><creatorcontrib>Rusch, Barbara</creatorcontrib><creatorcontrib>Telnov, Alex</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bastard, Mathieu</au><au>Molfino, Lucas</au><au>Mutaquiha, Cláudia</au><au>Galindo, Miriam Arago</au><au>Zindoga, Pereira</au><au>Vaz, Deise</au><au>Mahinça, Ivan</au><au>DuCros, Philipp</au><au>Rusch, Barbara</au><au>Telnov, Alex</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clin Infect Dis</addtitle><date>2019-10-30</date><risdate>2019</risdate><volume>69</volume><issue>10</issue><spage>1809</spage><epage>1811</epage><pages>1809-1811</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><abstract>Bedaquiline was recommended by the World Health Organization as the preferred option in treatment of multidrug-resistant tuberculosis (MDR-TB) with long regimens. However, no recommendation was given for the short MDR-TB regimen. Data from our small cohort of patients who switched from injectable drug to bedaquiline suggest that a bedaquiline-based short regimen is effective and safe.</abstract><cop>United States</cop><pmid>30901021</pmid><doi>10.1093/cid/ciz196</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1058-4838
ispartof Clinical infectious diseases, 2019-10, Vol.69 (10), p.1809-1811
issn 1058-4838
1537-6591
language eng
recordid cdi_proquest_miscellaneous_2196514447
source Oxford Journals Online
title Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A38%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20Outcomes%20of%20Patients%20Switching%20From%20an%20Injectable%20Drug%20to%20Bedaquiline%20During%20Short%20Standardized%20Treatment%20for%20Multidrug-resistant%20Tuberculosis%20in%20Mozambique&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Bastard,%20Mathieu&rft.date=2019-10-30&rft.volume=69&rft.issue=10&rft.spage=1809&rft.epage=1811&rft.pages=1809-1811&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1093/cid/ciz196&rft_dat=%3Cproquest_cross%3E2196514447%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c287t-923e5d7e115278fdf9a9811ce69875721091245064be3a140137b56b2b6352db3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2196514447&rft_id=info:pmid/30901021&rfr_iscdi=true